Immucell (ICCC) Non Operating Income (2020 - 2025)
Historic Non Operating Income for Immucell (ICCC) over the last 9 years, with Q3 2025 value amounting to -$155367.0.
- Immucell's Non Operating Income fell 2384.18% to -$155367.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$49703.0, marking a year-over-year increase of 9096.51%. This contributed to the annual value of -$506414.0 for FY2024, which is 221313.21% down from last year.
- Per Immucell's latest filing, its Non Operating Income stood at -$155367.0 for Q3 2025, which was down 2384.18% from -$124795.0 recorded in Q2 2025.
- Over the past 5 years, Immucell's Non Operating Income peaked at $331263.0 during Q1 2025, and registered a low of -$155367.0 during Q3 2025.
- Over the past 5 years, Immucell's median Non Operating Income value was -$73694.0 (recorded in 2023), while the average stood at -$52654.5.
- The largest annual percentage gain for Immucell's Non Operating Income in the last 5 years was 80966.85% (2023), contrasted with its biggest fall of 31403.9% (2023).
- Quarter analysis of 5 years shows Immucell's Non Operating Income stood at -$70156.0 in 2021, then skyrocketed by 53.53% to -$32602.0 in 2022, then tumbled by 314.04% to -$134985.0 in 2023, then rose by 25.32% to -$100804.0 in 2024, then crashed by 54.13% to -$155367.0 in 2025.
- Its Non Operating Income stands at -$155367.0 for Q3 2025, versus -$124795.0 for Q2 2025 and $331263.0 for Q1 2025.